A Double-Blind Placebo-Controlled study of the efficacy and safety of the p38 Map kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma.
- Year: 2009
- Type: Pharmaceutical - Pain
- Phase: II
- Indication: Neuropathic Pain
© Genesis Research Services, 2023